Shan J. serves as the Head, Associate Director of Analytical Development at Tonix Pharmaceuticals since June 2022, responsible for leading the Analytical department in developing methods for release and characterization in compliance with regulatory standards. Previous roles include Head, Associate Director of Analytical Development at Oncorus, Associate Director at Alaunos Therapeutics, Senior Scientist at Shire, and various analytical positions at QLB Biotherapeutics, ImmunoGen, Charles River Laboratories, and Harvard Medical School. Shan J. possesses extensive expertise in analytical development, bioanalytics, method validation, and regulatory submissions, complemented by a strong academic background with a Ph.D. in Bioanalytical and Bioorganic Chemistry from Georgia State University and a Mini-MBA from Harvard Business School.